GENXOTCHealthcare · Drug Manufacturers - Specialty & Generic

Genex Pharmaceutical, Inc.

$0.00+0.00%(+$0.00)

TickerSpark Score

67/100

Solid

100

Valuation

Profitability

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GENX research report →

52-Week Range0% of range

Low $0.00

Current $0.00

High $0.00

Companywww.genexpharma.com

Genex Pharmaceutical, Inc. produces and distributes Reconstituted Bone Xenograft (RBX) in the People's Republic of China. The RBX is a medical device that accelerates bone healing.

CEO: Fuzhi Song
IPO: 2004
Employees: 86
HQ: Tianjin City, CN

Price Chart

+0.00% · this period

Valuation

Market Cap: $1.79K
P/E: 0.01
P/S: 0.00
P/B: 0.00
EV/EBITDA: -0.54
Div Yield: 0.00%

Profitability

Gross Margin: 88.80%
Op Margin: 14.40%
Net Margin: 10.58%
ROE: 7.78%
ROIC: 4.21%

Growth & Income

Revenue: $3.24M · 32.77%
Net Income: $342.55K · -44.66%
EPS: $0.02 · -36.00%
Op Income: $466.14K
FCF YoY: -55.09%

Performance & Tape

52W High: $0.00
52W Low: $0.00
50D MA: $0.00
200D MA: $0.00
Beta: -0.55
Avg Volume: 118

Get TickerSpark's AI analysis on GENX

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime